GL1X · GenesisL1 explorer

Research workbench

The first ketoreductase of the erythromycin synthase (crystal form 1)

Analyse The first ketoreductase of the erythromycin synthase (crystal form 1) in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2FR0
Type
protein
Length
468 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Erythromycin synthase, eryai
EC
1.1.1.100
UniProt
Q03131
Ligands
NDP
Pockets
6 · best druggability 0.71

Structure

x-ray diffraction · 1 distinct chain · 37% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AErythromycin synthase, eryai (EC 1.1.1.100)protein46837% helix, 21% strandQ03131

Ligands and binding sites

  • NDP · Nadph dihydro-nicotinamide-adenine-dinucleotide phosphate · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13060.710.8541empty
24560.680.7942NDP
31380.570.8220empty
41290.450.7725empty
5980.420.7825empty

Compared structures

  • 2FR0 · The first ketoreductase of the erythromycin synthase (crystal form 1) · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.